MedPath

The effect of hesperidin supplement in the treatment of myocardial infarctio

Not Applicable
Conditions
Myocardial infarction.
Acute myocardial infarction
Registration Number
IRCT201704099472N12
Lead Sponsor
Iran university of medical science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Risk of myocardial infarction,According to to diagnosis of profession and clinical symptoms Including:1.Chest pain for at least 20 minutes.2.Clearly electrocardiographic changes.3.Evidence of increased cardiac enzyme levels(According to :Depression treatment after myocardial infarction and long term risk of subsequent cardiovascular events and mortality:A randomized controlled tial article);The patient agreed to enter the study and willingness to cooperate and Signed informed consent;The use of any supplements, including:Antioxidant and vitamins during the last 3 months;The absence of any allergies(Gastrointestinal and skin) to Each type of antioxidant supplements and vitamins;MI Patients with up to 6 weeks after discharge ;40-25:BMI;30-70:Age;Not taking more than one blood orange or two of other citrus in a day
Exclusion criteria:Lack of follow-up after discharge;Patient dissatisfaction or Not wanting to continue the cooperation of the patient for any reason ;The use of antioxidant supplements and vitamins and Q10 supplement;Find allergy symptoms at any time during the study; Suffering from Uncontrolled chronic diseases(Liver dysfunction, kidney failure, diabetes, etc.);Gastrointestinal disorders
Compliance below the 80%;Taking antibiotics and catching infectious diseases
No entry criteria:Taking more than 500 ml per day of drinks and food sources rich in flavonoids(Green tea, coffee, citrus juice, which is determined through a entry criteria questionnaire;Dont use of heparin and Varfarin;Unable to follow-up patient after discharge;Smoking and tobacco;Any allergies to any kind of vitamin supplements;Pregnancy and lactation;Suffering from any Uncontrolled metabolic disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath